Form RD-1 2004 Survey of Industrial Research & Development

R

EA

S

BU

US

CE
ER

U.S.
D

M

EP

ENT OF C
TM
OM
AR

EN
U O
F TH E C

U.S. DEPARTMENT OF COMMERCE
Economics and Statistics Administration

U.S. CENSUS BUREAU
FORM

RD-1

2004 SURVEY OF INDUSTRIAL RESEARCH AND
DEVELOPMENT
OMB No. : Approval Expires

(DRAFT)

Mail your completed form to:
U.S. CENSUS BUREAU
1201 East 10th Street
Jeffersonville, IN 47132-0001

DRAFT

Please read the accompanying
instructions before answering the
questions.
Need help or have questions
about filling out this form?
Visit our Web site at
www.census.gov/econhelp/rd
To speak with an analyst,
call 1-800-851-2014, option "0"
between 8:00 a.m. and 5:00 p.m.,
Eastern time, Monday through
Friday.

9/23/04

- OR Write to the address above,
include your 11-digit Identification
Number (ID) printed in the mailing
address.

(Please correct any errors in this mailing address.)

YOUR RESPONSE IS REQUIRED BY LAW. Title 13, United States Code, requires businesses and other
organizations that receive this questionnaire to answer the questions and return the report to the U.S. Census
Bureau. By the same law, YOUR CENSUS REPORT IS CONFIDENTIAL. It may be seen only by persons sworn
to uphold the confidentiality of Census Bureau information and may be used only for statistical purposes. Further,
copies retained in respondents' files are immune from legal process.
You will satisfy the mandatory requirements for this survey if you answer 2 , lines A and B; 4 , line D, columns 1
and 2; and 11 .
Except as noted, this report covers your entire consolidated domestic enterprise, including all U.S. subsidiaries, affiliates, and
branches. Reasonable estimates are acceptable.
1

Was this company owned or controlled by another company on December 31, 2004?
Yes - See instructions to determine if you should complete this questionnaire.
No - Go to

2

.
2004

HOW TO REPORT
DOLLAR FIGURES
2

Dollar figures should be rounded to thousands of dollars.
If a figure is $1,025,628.79:

$ Billions

Millions

1 0 2 6

Report

A. What was the amount of your company's sales, shipments,
operating receipts, or revenues, net of returns and
allowances attributable to domestic operations in the 50
United States or D.C. during 2004? (EXCLUDE domestic
intracompany transfers and sales by foreign subsidiaries.
INCLUDE receipts for sales of products and services provided
to other companies, individuals, U.S. Government agencies,
and foreign countries.) . . . . . . . . . . . . . . . . . . . Mark "X" if None

Thousands

2004
$ Billions

Millions

Thousands

102

Amount reported in 2003

B. How many employees worked in the 50 United States or D.C.
for your company on March 12, 2004? (Include number of
full- and part-time employees whose payroll was reported
on Internal Revenue Service Form 941, Employer's Quarterly
Federal Tax Return.) . . . . . . . . . . . . . . . . . . . . Mark "X" if None

Number
112

Amount reported in 2003
Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 2

Form RD-1
3

Page 2

(DRAFT)

What was the number of full-time equivalent (FTE) scientists and engineers employed by
your company as of January 1, 2005 who worked on the following types of R&D during
2004?
(See instructions for the definition of FTE scientists and engineers.)

January 1, 2005
Number of FTEs
204

A. Federally funded R&D . . . . . . . . . . . . . . . . . . . Mark "X" if None
Number of FTEs reported as of January 1, 2004
205

B. Company and other nonfederally funded R&D . . . . . . . . Mark "X" if None
Number of FTEs reported as of January 1, 2004
206

C. TOTAL (Add lines A and B.) . . . . . . . . . . . . . . . . Mark "X" if None
Number of FTEs reported as of January 1, 2004

4

What was the cost of R&D performed within your company in the 50 United States and D.C. during 2004?
(Please report R&D performed for each source of funding.)
2004

A. Basic research (Research
for the advancement
of scientific knowledge
without specific immediate
commercial objectives.)
Mark "X" if no basic
research . . . . . .

$ Billions

(1)

(2)

Federal funds

Company and other
nonfederal funds

Millions

Thousands

304

$ Billions

Millions

Thousands

305

(3)
Total funds
Columns 1 + 2
$ Billions

Millions

Thousands

306

Amount reported in 2003

B. Applied research
(Research directed
primarily towards a
specific commercial or
practical objective.)
Mark "X" if no
applied research . .

$ Billions

(1)

(2)

(3)

Federal funds

Company and other
nonfederal funds

Total funds
Columns 1 + 2

Millions

Thousands

314

$ Billions

Millions

Thousands

315

$ Billions

Millions

Thousands

316

Amount reported in 2003

C. Development (Activity
translating research into
new or improved goods,
services or processes.)
Mark "X" if no
development . . . .

$ Billions

(1)

(2)

Federal funds

Company and other
nonfederal funds

Millions

Thousands

324

$ Billions

Millions

Thousands

325

(3)
Total funds
Columns 1 + 2
$ Billions

Millions

Thousands

326

Amount reported in 2003

D. TOTAL (Add lines A
through C.)

$ Billions
344

(1)

(2)

Federal funds

Company and other
nonfederal funds

Millions

Thousands

$ Billions
345

Millions

Thousands

(3)
Total funds
Columns 1 + 2
$ Billions

Millions

Thousands

346

Mark "X" if no R&D
Amount reported in 2003
Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 3

Form RD-1

Page 3

(DRAFT)

If not shown, please enter your 11-digit Identification
Number (ID) from the mailing address.
5

6

For 2005 what is your
projected cost for companyfunded R&D performed by
your company in the 50
United States and D.C.?
(Comparable to the 2004
figure reported in 4 , line D,
column 2.)
Mark "X" if no R&D is
planned for next year

2005

$ Billions

Mark "X" if no R&D
was performed by
others . . . . . . .

(2)

Federal funds

Company and other
nonfederal funds

Millions

Thousands

000

$ Billions

Millions

Thousands

000

A. What was the cost of R&D
performed by others for
your company in the 50
United States and D.C.
during 2004?
(Please report R&D
performed for each source
of funding.)

(1)

(3)
Total funds
Columns 1 + 2
$ Billions

Millions

Thousands

401

2004

$ Billions

(1)

(2)

Federal funds

Company and other
nonfederal funds

Millions

Thousands

354

$ Billions

Millions

Thousands

355

(3)
Total funds
Columns 1 + 2
$ Billions

Millions

Thousands

356

Amount reported in 2003
2004

B. What was the cost of company-funded R&D performed
by others for your company in the 50 United States and
D.C. by the following types of organizations during 2004?

Company and other
nonfederal funds
$ Billions

Millions

Thousands

811

1. For-profit companies . . . . Mark "X" if None
Amount reported in 2003
000

2. Federal agencies or
laboratories . . . . . . . . . Mark "X" if None
Amount reported in 2003
000

3. State government agencies
or laboratories . . . . . . . Mark "X" if None
Amount reported in 2003
821

4. Universities or colleges . . . Mark "X" if None
Amount reported in 2003
831

5. Other nonprofit organizations Mark "X" if None
Amount reported in 2003

6. TOTAL (Add lines 1 through
5. The sum should equal
the total reported in line A,
column 2.) . . . . . . . . . Mark "X" if None

841

Amount reported in 2003

Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 4

Form RD-1
7

Page 4

(DRAFT)

A. What was the cost of your company-funded R&D
performed outside of the 50 United States and D.C. by
subsidiaries, affiliates, branches, or by other organizations
in which your company owns the following percentages of
voting stock or equivalent interest during 2004?
Mark "X" if None
1.

0% - No ownership . . . . . . . . . . . . . .

2004
Company and other
nonfederal funds
$ Billions

Millions

Thousands

363

Amount reported in 2003

2.

More than 0% but less than 10% ownership . . .

364

Amount reported in 2003

3.

10%-50% ownership . . . . . . . . . . . . . .

365

Amount reported in 2003

4.

More than 50% ownership . . . . . . . . . . .

366

Amount reported in 2003

5.

TOTAL (Add lines 1 through 4.) . . . . . . . .

369

Amount reported in 2003

B. What was the cost of your company-funded R&D that
was performed outside the 50 United States and D.C.
by your subsidiaries, affiliates, or branches, or by other
organizations in which your company owns more than 50%
of the voting stock or equivalent interest in the following
countries and Puerto Rico during 2004?
1.

1206

Puerto Rico . . . . . . . . . Mark "X" if None
Amount reported in 2003
1201

2.

Canada . . . . . . . . . . . Mark "X" if None
Amount reported in 2003
0000

3.

China . . . . . . . . . . . . Mark "X" if None
Amount reported in 2003
1203

4.

France. . . . . . . . . . . . Mark "X" if None
Amount reported in 2003
1202

5.

Germany . . . . . . . . . . Mark "X" if None
Amount reported in 2003
0000

6.

India . . . . . . . . . . . . Mark "X" if None
Amount reported in 2003
CONTINUE WITH

7

B ON PAGE 5

Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 5

Form RD-1

Page 5

(DRAFT)

If not shown, please enter your 11-digit Identification
Number (ID) from the mailing address.

7

B. What was the cost of your company-funded R&D that
was performed outside the 50 United States and D.C.
by your subsidiaries, affiliates, or branches, or by other
organizations in which your company owns more than 50%
of the voting stock or equivalent interest in the following
countries and Puerto Rico during 2004? - Continued

2004
Company and other
nonfederal funds
$ Billions

Millions

Thousands

0000

7.

Ireland

Mark "X" if None
Amount reported in 2003
0000

8.

Isreal . . . . . . . . . . . . Mark "X" if None
Amount reported in 2003
0000

9.

Italy . . . . . . . . . . . . . Mark "X" if None
Amount reported in 2003
1204

10. Japan . . . . . . . . . . . . Mark "X" if None
Amount reported in 2003
0000

11. Singapore . . . . . . . . . . Mark "X" if None
Amount reported in 2003
0000

12. Sweden . . . . . . . . . . . Mark "X" if None
Amount reported in 2003
1205

13. United Kingdom . . . . . . . Mark "X" if None
Amount reported in 2003

14. Other - Specify

1207

1209

Amount reported in 2003
0000
0000
0000
0000

15. TOTAL (Add lines 1 through
14. The sum should equal the
amount reported in line A4.) Mark "X" if None

1210

Amount reported in 2003

Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 6

Form RD-1(DRAFT)
8

Page 6
2004

What was the cost of the Federally funded R&D your company
performed in the 50 United States and D.C. for each of these
Federal agencies during 2004?

Company and other
nonfederal funds
$ Billions

Millions

Thousands

511

A. Department of Defense (DoD) . . . Mark "X" if None
Amount reported in 2003
521

B. National Aeronautics and Space
Administration (NASA) . . . . . . Mark "X" if None
Amount reported in 2003
531

C. Department of Energy (DOE) . . . Mark "X" if None
Amount reported in 2003
541

D. Other Federal agencies . . . . . . Mark "X" if None
Amount reported in 2003

E. TOTAL (Add lines A through D.
The sum should equal the total
reported in 4 , line D, column 1.)

551

Mark "X" if None
Amount reported in 2003

Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 7

Form RD-1

Page 7

(DRAFT)

If not shown, please enter your 11-digit Identification
Number (ID) from the mailing address.
9

What was the cost relating to the total R&D performed
within your company in the 50 United States and D.C. for the
following types of expenses during 2004?

2004
Total funds
$ Billions

Millions

Thousands

A. Wages and salaries of R&D personnel
(Include scientists and engineers,
technicians, secretaries, and other
personnel.) . . . . . . . . . . . . Mark "X" if None

611

Amount reported in 2003

B. Fringe benefits of R&D personnel
(Include taxable and nontaxable
benefits, 401K plans, employers'
contribution to health plans.) . . . Mark "X" if None

621

Amount reported in 2003

C. Materials and supplies consumed
(Include the cost of all purchased
materials consumed.) . . . . . . . Mark "X" if None

631

Amount reported in 2003

D. Depreciation on R&D property and
equipment
(Include depreciation and
amortization costs for property
and equipment used for R&D
during the year.) . . . . . . . . . Mark "X" if None

641

Amount reported in 2003

E. All other R&D expenses
(Include R&Ds share of company
overhead and other expenses such
as utilities, books and periodicals,
and property and other taxes.) . . Mark "X" if None

651

Amount reported in 2003

F. TOTAL (Add lines A through E.
The sum should equal the total
reported in 4 , line D, column 3.)

661

Mark "X" if None
Amount reported in 2003

Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 8

Form RD-1(DRAFT)

Page 8

10 A. What was the cost rlating to total R&D performed within
your company in the 50 United States and D.C. for the
following types of technologies during 2004?
1. Biotechnology (The use of
scientific and engineering
data and techniques for
the study and solution of
problems concerning living
organisms.) . . . . . . . . . Mark "X" if None

2004
Total funds
$ Billions

Millions

Thousands

7111

Amount reported in 2003

2. Software development (The
formulation of programs,
applications, routines, etc.,
for computers, excluding
those used exclusively
for internal company
operations.) . . . . . . . . . Mark "X" if None

7211

Amount reported in 2003

3. Materials synthesis and
processing (The use of
scientific and engineering
data and techniques
for the formulation and
manipulation of new
materials.) . . . . . . . . . Mark "X" if None

7311

Amount reported in 2003
7411

4. Other areas . . . . . . . . . Mark "X" if None
Amount reported in 2003

5. TOTAL (Add lines 1 through
4. The sum should equal the
total reported in 4 , line D,
column 3.) . . . . . . . . . Mark "X" if None

7511

Amount reported in 2003

Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 9

Form RD-1

Page 9

(DRAFT)

If not shown, please enter your 11-digit Identification
Number (ID) from the mailing address.

10 B. What percentage of the R&D costs reported in 10 A are attributable to
nanotechnology for each of the following types of technologies during
2004? (Nanotechnology is defined as the creation and utilization of
materials, devices, and systems through the control of matter on the
nanometer scale, at the level of atoms and molecules in the range of 1
to 100 nanometers.)

2004
Whole
percents
7112

%

1. Biotechnology . . . . . . . . . . . . . . Mark "X" if None

%

Amount reported in 2003
7212

%

2. Software development . . . . . . . . . . Mark "X" if None

%

Amount reported in 2003
7312

%

3. Materials synthesis and process . . . . . . Mark "X" if None

%

Amount reported in 2003
7412

%

4. Other areas . . . . . . . . . . . . . . . Mark "X" if None

%

Amount reported in 2003

11 What was the cost of the R&D your company performed in each of the 50 United States and D.C during 2004?
(Please report Federally funded and total R&D performed.)
2004
Line
No.

(1)
Federal funds

State
$ Billions

Millions

Thousands

(2)
Total funds
$ Billions

9011

9012

9021

9022

9031

9032

9041

9042

9051

9052

Millions

Thousands

1 Alabama . . . . . . . .
Amount reported in 2003

2 Alaska . . . . . . . . .
Amount reported in 2003

3 Arizona . . . . . . . . .
Amount reported in 2003

4 Arkansas . . . . . . . .
Amount reported in 2003

5 California . . . . . . . .
Amount reported in 2003
CONTINUE WITH 11 ON PAGE 10
Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 10

Form RD-1

Page 10

(DRAFT)

11 What was the cost of the R&D your company performed in each of the 50 United States and D.C during 2004?
(Please report R&D performed for each source of funding.) - Continued
2004
Line
No.

(1)
Federal funds

State
$ Billions

Millions

Thousands

(2)
Total funds
$ Billions

9061

9062

9071

9072

9081

9082

9091

9092

9101

9102

9111

9112

9121

9122

9131

9132

9141

9142

9151

9152

Millions

Thousands

6 Colorado . . . . . . . .
Amount reported in 2003

7 Connecticut . . . . . . .
Amount reported in 2003

8 Delaware . . . . . . . .
Amount reported in 2003

9 District of Columbia . . .
Amount reported in 2003

10 Florida . . . . . . . . .
Amount reported in 2003

11 Georgia . . . . . . . . .
Amount reported in 2003

12 Hawaii . . . . . . . . .
Amount reported in 2003

13 Idaho . . . . . . . . . .
Amount reported in 2003

14 Illinois . . . . . . . . .
Amount reported in 2003

15 Indiana . . . . . . . . .
Amount reported in 2003

CONTINUE WITH 11 ON PAGE 11
Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 11

Form RD-1

Page 11

(DRAFT)

If not shown, please enter your 11-digit Identification
Number (ID) from the mailing address.

11 What was the cost of the R&D your company performed in each of the 50 United States and D.C during 2004?
(Please report R&D performed for each source of funding.) - Continued
2004
Line
No.

(1)
Federal funds

State
$ Billions

Millions

Thousands

(2)
Total funds
$ Billions

9161

9162

9171

9172

9181

9182

9191

9192

9201

9202

9211

9212

9221

9222

9231

9232

9241

9242

9251

9252

Millions

Thousands

16 Iowa . . . . . . . . . .
Amount reported in 2003

17 Kansas . . . . . . . . .
Amount reported in 2003

18 Kentucky . . . . . . . .
Amount reported in 2003

19 Louisiana . . . . . . . .
Amount reported in 2003

20 Maine . . . . . . . . .
Amount reported in 2003

21 Maryland . . . . . . . .
Amount reported in 2003

22 Massachusetts . . . . .
Amount reported in 2003

23 Michigan . . . . . . . .
Amount reported in 2003

24 Minnesota . . . . . . .
Amount reported in 2003

25 Mississippi . . . . . . .
Amount reported in 2003

CONTINUE WITH 11 ON PAGE 12
Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 12

Form RD-1

Page 12

(DRAFT)

11 What was the cost of the R&D your company performed in each of the 50 United States and D.C during 2004?
(Please report R&D performed for each source of funding.) - Continued
2004
Line
No.

(1)
Federal funds

State
$ Billions

Millions

Thousands

(2)
Total funds
$ Billions

9261

9262

9271

9272

9281

9282

9291

9292

9301

9302

9311

9312

9321

9322

9331

9332

9341

9342

9351

9352

Millions

Thousands

26 Missouri . . . . . . . .
Amount reported in 2003

27 Montana . . . . . . . .
Amount reported in 2003

28 Nebraska . . . . . . . .
Amount reported in 2003

29 Nevada . . . . . . . . .
Amount reported in 2003

30 New Hampshire . . . . .
Amount reported in 2003

31 New Jersey . . . . . . .
Amount reported in 2003

32 New Mexico . . . . . .
Amount reported in 2003

33 New York . . . . . . . .
Amount reported in 2003

34 North Carolina . . . . .
Amount reported in 2003

35 North Dakota . . . . . .
Amount reported in 2003

CONTINUE WITH 11 ON PAGE 13
Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 13

Form RD-1

Page 13

(DRAFT)

If not shown, please enter your 11-digit Identification
Number (ID) from the mailing address.

11 What was the cost of the R&D your company performed in each of the 50 United States and D.C during 2004?
(Please report R&D performed for each source of funding.) - Continued
2004
Line
No.

(1)
Federal funds

State
$ Billions

Millions

Thousands

(2)
Total funds
$ Billions

9361

9362

9371

9372

9381

9382

9391

9392

9401

9402

9411

9412

9421

9422

9431

9432

9441

9442

9451

9452

Millions

Thousands

36 Ohio . . . . . . . . . .
Amount reported in 2003

37 Oklahoma. . . . . . . .
Amount reported in 2003

38 Oregon . . . . . . . . .
Amount reported in 2003

39 Pennsylvania . . . . . .
Amount reported in 2003

40 Rhode Island . . . . . .
Amount reported in 2003

41 South Carolina . . . . .
Amount reported in 2003

42 South Dakota . . . . . .
Amount reported in 2003

43 Tennessee . . . . . . .
Amount reported in 2003

44 Texas . . . . . . . . . .
Amount reported in 2003

45 Utah . . . . . . . . . .
Amount reported in 2003

CONTINUE WITH 11 ON PAGE 14

Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 14

Form RD-1

Page 14

(DRAFT)

11 What was the cost of the R&D your company performed in each of the 50 United States and D.C during 2004?
(Please report R&D performed for each source of funding.) - Continued
2004
Line
No.

(1)
Federal funds

State
$ Billions

Millions

Thousands

(2)
Total funds
$ Billions

9461

9462

9471

9472

9481

9482

9491

9492

9501

9502

9511

9512

9541

9542

Millions

Thousands

46 Vermont . . . . . . . .
Amount reported in 2003

47 Virginia . . . . . . . . .
Amount reported in 2003

48 Washington . . . . . . .
Amount reported in 2003

49 West Virginia . . . . . .
Amount reported in 2003

50 Wisconsin . . . . . . .
Amount reported in 2003

51 Wyoming . . . . . . . .
Amount reported in 2003

TOTAL (Add lines 1
through 51. The sum
should equal the totals
reported in 4 , line D,
columns 1 and 3.) . . . .
Amount reported in 2003

Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 15

Form RD-1

Page 15

(DRAFT)

If not shown, please enter your 11-digit Identification
Number (ID) from the mailing address.
12 What was the cost of the energy-related R&D your company
performed in the 50 United States and D.C. during 2004?
(Include the portion of project cost incurred for the purpose
of increasing energy resources or capabilities for each
source of funding. These expenditures should also be
included as part of the information reported in 4 , line D,
columns 1 and 3.)

2004
(1)
Federal funds
$ Billions

Millions

Thousands

(2)
Total funds
$ Billions

10211

10212

10311

10312

10111

10112

10411

10412

10511

10512

Millions

Thousands

A. Fossil fuels . . . . Mark "X" if no fossil fuel R&D
was performed
Amount reported in 2003

B. Geothermal and
solar . . . . . . . Mark "X" if no geothermal or
solar R&D was performed
Amount reported in 2003

C. Nuclear . . . . . . Mark "X" no nuclear R&D
was performed
Amount reported in 2003

D. All other energy
sources . . . . . . Mark "X" if no energy R&D
was performed
Amount reported in 2003

E. TOTAL (Add lines
A through D.) . . . Mark "X" if None
Amount reported in 2003

Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 16

Form RD-1

Page 16

(DRAFT)

13 What was the cost of the R&D performed by your company in
the 50 United States and D.C. company-funded in collaboration
with the type of R&D partner listed below during 2004?
(These expenditures should also be included as part of the
information reported in 4 , line D, column 2.)

2004
Company and other
nonfederal funds
$ Billions

Millions

Thousands

1101

A. For-profit companies . . . . . . . Mark "X" if None
Amount reported in 2003
1102

B. Federal agencies or laboratories . . Mark "X" if None
Amount reported in 2003
0000

C. State government agencies or
laboratories . . . . . . . . . . . Mark "X" if None
Amount reported in 2003
1103

D. Universities or colleges . . . . . . Mark "X" if None
Amount reported in 2003
1104

E. Other nonprofit organizations . . . Mark "X" if None
Amount reported in 2003
1110

F. TOTAL (Add lines A through E.) . . Mark "X" if None
Amount reported in 2003

Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 17

Form RD-1

Page 17

(DRAFT)

If not shown, please enter your 11-digit Identification
Number (ID) from the mailing address.
14 A. Do the R&D expenditures reported on this form cover the entire fully consolidated enterprise, including all
subsidiaries, affiliates, or branches located in the 50 United States and D.C.? (Mark "X" only ONE box.)
1301

Yes

0000

No - Please explain in 16 .

B. Was your company publicly or privately owned? (Mark "X" only ONE box.)
1302

Publicly owned

0000

Privately owned

0000

Other - Please describe

C. Other than the parent company, how many subsidiaries, affiliates, or branches located in the 50 United States
and D.C. owned or controlled by your company (by means of voting stock or other equivalent interest) are
included in this report? (Mark "X" only ONE box.)
1303

None

1304

1

1305

2-5

1306

More than 5

D. Other than the parent company, how many subsidiaries, affiliates, or branches located outside the 50 United
States and D.C. owned or controlled by your company (by means of voting stock or other equivalent interest)
are included in this report? (Mark "X" only ONE box.)
1307

None

1308

1

1309

2-5

1310

More than 5

E. What percent of your company was owned or controlled (by means of voting stock or other equivalent interest) by
one or more companies located in the 50 United States and D.C.? (Mark "X" only ONE box.)
1311

0% - No ownership

1312

More than 0% but less than 10% ownership

1313

10%-50% ownership

1314

More than 50% ownership

F. What percent of your company was owned or controlled (by means of voting stock or other equivalent interest) by
one or more companies located outside the 50 United States and D.C.? (Mark "X" only ONE box.)
1315

0% ownership

1316

More than 0% but less than 10% ownership

1317

10%-50% ownership

1318

More than 50% ownership

Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM

CONTINUE ON PAGE 18

Form RD-1

Page 18

(DRAFT)

15 REPORTING PERIOD AND CONTACT INFORMATION
A. Is the time period covered by this report a calendar year?
0078

Yes

0079

No - Enter time period covered

Month
FROM

Year

Month
TO

0070

Year

0071

B. Are your company's R&D records and data in a central location?
0000

Yes

0000

No - How many locations?

C. Did more than one person complete this form?

0072

0000

Yes

0000

No - How many?

Area code
Telephone
0076

0073

Name of person to contact regarding this report

0074

Number

Title

Extension

-

Area code
Fax

Number

-

0075

Month

Internet e-mail address
Date
completed

Day

Year

0069

16 REMARKS (Please use this space for any explanations that may help us in understanding your reported data.)

Thank you for completing your 2004 SURVEY OF INDUSTRIAL RESEARCH AND
DEVELOPMENT form.
PLEASE PHOTOCOPY THIS FORM FOR YOUR RECORDS AND RETURN THE ORIGINAL.
Produced by GIDS AutoFormatter v4.30,
on 23-Sep-2004 at 04:24 PM